Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 9,295
Sort by:

Toxoplasmosis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Toxoplasmosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis – Drugs In Development, 2021,...

December 2021 48 pages

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gui...

December 2021 62 pages

Western Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Western Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Western Equine Encephalitis –...

December 2021 33 pages

Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections – Drugs In Dev...

December 2021 258 pages

Global Vitamin C Market 2021 - Industry Statistics

US$ 750.00

Vitamin C, also known as L-ascorbic acid, is a water-soluble vitamin that is naturally present in some foods, added to others, and available as a dietary supplement. Humans, unlike most animals, are u...

December 2021 70 pages

Global Vitamins Market 2021 - Industry Statistics

US$ 2,800.00

Vitamins are organic substances present in minute amounts in natural foodstuffs. It is an essential micronutrient which an organism needs in small quantities for the proper functioning of its metaboli...

December 2021 88 pages

Global Vitamin B1 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B1, or thiamin (thiamine), is a water-soluble vitamin found naturally in some foods, added to foods, and sold as a supplement. Vitamin B1 plays a vital role in the growth and function of vario...

December 2021 63 pages

Global Vitamin B12 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B12 is an important B vitamin. It is crucial for nerve tissue health, brain function, and the production of red blood cells. The global vitamin B12 market is projected to expand at a CAGR of ~...

December 2021 62 pages

Global Vitamin B6 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B6, or pyridoxine, is a water-soluble vitamin found naturally in many foods, as well as added to foods and supplements. According to latest analysis by Gen Consulting Company, the global vitam...

December 2021 61 pages

Global Vitamin B7 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B7, also known as biotin, vitamin H, is a water-soluble vitamin that helps the body metabolize fats, carbohydrates, and protein. Vitamin B7 supplements are often glamorized as a treatment for...

December 2021 73 pages

Global Vitamin B9 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B9, also called folate or folic acid, is one of 8 B vitamins. All B vitamins help the body convert food (carbohydrates) into fuel (glucose), which is used to produce energy. According to marke...

December 2021 60 pages

Global Vitamin B2 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B2, or riboflavin, is one of eight B vitamins that are essential for human health. It is essential to the formation of two major coenzymes, flavin mononucleotide and flavin adenine dinucleotid...

December 2021 72 pages

Global Vitamin D3 Market 2021 - Industry Statistics

US$ 750.00

Vitamin D helps regulate the amount of calcium and phosphate in the body. These nutrients are needed to keep bones, teeth and muscles healthy. In humans, the most important compounds in this group are...

December 2021 65 pages

Global Vitamin E Market 2021 - Industry Statistics

US$ 750.00

Vitamin E is a group of eight fat soluble compounds that include four tocopherols and four tocotrienols. Vitamin E helps maintain healthy skin and eyes, and strengthen the body's natural defence again...

December 2021 66 pages

Global Antibiotics Market – Analysis By Drug Class (Beta-Lactams, Cephalosporins, Lipopeptide, Others), Mechanism, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

US$ 2,400.00

Executive According to Azoth Analytics research report, the Global Antibiotic Market was valued at USD 46.66 Billion in the year 2020 with North America leading the regional market share. Growth in th...

November 2021 220 pages

Asia Pacific Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity

US$ 2,295.00

Asia Pacific drug discovery market will grow by 10.6% annually with a total addressable market cap of $231.8 billion over 2021-2030 owing the rising demand for specialty medicines, the surge in lifest...

November 2021 120 pages

Europe Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity

US$ 2,295.00

Europe drug discovery market was valued at $14.8 billion in 2020 and will grow by 8.3% annually over 2020-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases...

November 2021 123 pages

Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity

US$ 2,720.00

Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases an...

November 2021 181 pages

North America Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity

US$ 2,295.00

North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising demand for specialty medicines, the surge in lifes...

November 2021 117 pages

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021

US$ 3,500.00

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021 SUMMARY 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - 5?-Nucleotidase (5NT) i...

November 2021 145 pages

Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021

US$ 2,000.00

Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic...

November 2021 170 pages

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Drugs in Development, 2021

US$ 3,500.00

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Drugs in Development, 2021 SUMMARY Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Bcl-2-like protein 1 is a pro...

November 2021 66 pages

Bladder Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Bladder Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Drugs In Development, 2021, provides...

November 2021 2564 pages

Bullous Pemphigoid (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Bullous Pemphigoid (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bullous Pemphigoid - Drugs In Development, 202...

November 2021 177 pages

Canavan Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Canavan Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Drugs In Development...

November 2021 35 pages

Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) pipeline Target constitutes c...

November 2021 51 pages

Encephalopathy (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Encephalopathy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Drugs In Development,...

November 2021 113 pages

Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastrointestinal Stromal Tumor...

November 2021 866 pages

Gaucher Disease - Drugs in Development, 2021

US$ 2,000.00

Gaucher Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Drugs In Development, 2021, provides an overv...

November 2021 143 pages

Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Globoid C...

November 2021 79 pages

Graves Diseases (Hormonal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Graves Diseases (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Drugs In Development, 20...

November 2021 102 pages

Heart Transplant Rejection (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Heart Transplant Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heart Transplant Rejection - Drugs In D...

November 2021 40 pages

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...

November 2021 157 pages

Huntington Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Huntington Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Drugs In Devel...

November 2021 423 pages

Hypertension (Cardiovascular) - Drugs in Development, 2021

US$ 2,500.00

Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Drugs In Development, 2021, provid...

November 2021 872 pages

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021

US$ 3,500.00

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Integrin Alpha 4 - Drugs I...

November 2021 126 pages

Keloids (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Keloids (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keloids - Drugs In Development, 2021, provides an overvie...

November 2021 51 pages

Liver Failure (Hepatic Insufficiency) (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Liver Failure (Hepatic Insufficiency) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Failure - Drugs...

November 2021 143 pages

Macular Edema (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Macular Edema (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Drugs In Development, 2021, provi...

November 2021 102 pages

Melanoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Drugs In Development, 2021, provides an overview...

November 2021 4610 pages

Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metachromatic Leuko...

November 2021 51 pages

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis I - Dru...

November 2021 110 pages

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis II -...

November 2021 88 pages

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis...

November 2021 115 pages

Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Drugs In Devel...

November 2021 1320 pages

Filters

Search

Publishers

1
318
174
29
4
667
409
35
27
971
77
19
16
425
2
21
1
16
111
1
5
9
2,264
5
4
31
6
142
1
17
15
248
651
89
1
373
26
34
586
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
109
28
19
4
7
3
324
15
1
23
72
24
29
44
296
17
18
2

Regions

131
40
38
37
37
35
32
21
12
10
10
9
9
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
90
12
354
31
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
38
4
4
3
3
3
1
1
3
9
7,953

Price

Date

Pages

Offers

9
1